EMERYVILLE, Calif., Sept. 27, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, announced the Opto® Memory B Discovery Human workflow, further expanding diversity of antibodies customers can discover on the Beacon® optofluidic platform. The new workflow and reagents, to be commercially available by the end of…Read More
PhenomeX Announces Opto Memory B Discovery Human Workflow on the Beacon Optofluidic Platform
